4.8 Article

Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

Journal

BIOMATERIALS
Volume 35, Issue 10, Pages 3331-3339

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2013.12.095

Keywords

Co-delivery system; Layered double hydroxide; Electrostatic assembly; Apoptosis

Funding

  1. ARC Future Fellowship [FT120100813]
  2. ARC DP [DP120104792]
  3. University of Queensland Postdoctoral Fellowship
  4. UQ early-career-research grant

Ask authors/readers for more resources

In this research we employed layered double hydroxide nanoparticles (LDHs) to simultaneously deliver an anticancer drug 5-fluorouracil (5-FU) and Allstars Cell Death siRNA (CD-siRNA) for effective cancer treatment. The strategy takes advantage of the LDH anion exchange capacity to intercalate 5-FU into its interlayer spacing and load siRNA on the surface of LDH nanoparticles. LDH nanoparticles have been previously demonstrated as an effective cellular delivery system for 5-FU and siRNA separately in various investigations. More excitedly, the combination of CD-siRNA and anticancer drug 5-FU with the same LDH particles significantly enhanced cytotoxicity to three cancer cell lines, e.g. MCF-7, U2OS and HCT-116, compared to the single treatment with either CD-siRNA or 5-FU. This enhancement is probably a result of coordinate mitochondrial damage process. Thus, the strategy to co-deliver siRNA and an anticancer drug by LDHs has great potential to overcome the drug resistance and enhance cancer treatment. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available